BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial Neoplasia: Evidence and Implications
Open Access
- 31 May 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (5) , 1767-1771
- https://doi.org/10.1016/s0002-9440(10)65047-x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutationNature Genetics, 1997
- Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.Genes & Development, 1997
- Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patientsNature Genetics, 1997
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesNature Medicine, 1996
- Low incidence of BRCA2 mutations in breast carcinoma and other cancersNature Genetics, 1996
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer familiesNature Genetics, 1996
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNature Genetics, 1996
- Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP)Human Molecular Genetics, 1992
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesisVirchows Archiv, 1980